Phathom Pharmaceuticals PHAT
NASDAQ PHAT
$7.34 -0.02 (-0.27%)
As of: Sep 30, 2026 · 1:22 PM EDT

Phathom Pharmaceuticals, Inc. (PHAT) Short term Debt (2020 - 2021)

Updated

Phathom Pharmaceuticals (PHAT) posted Short term Debt of $10.35 million for Q2 2021, up 644.8% from $1.39 million a year earlier but down 12.1% from the prior quarter.

Analysis

Phathom Pharmaceuticals, Inc. (PHAT) Short term Debt (2020 - 2021) Analysis & Trends

At the end of FY2020, Phathom Pharmaceuticals' Short term Debt came in at $7.35 million.

  • Quarterly Short term Debt has run from a low of $1.39 million in Q2 2020 to a high of $11.77 million in Q1 2021 over five years.
  • According to Business Quant data, Short term Debt for the three prior quarters was $11.77 million (Q1 2021), $7.35 million (Q4 2020) and $5.56 million (Q3 2020).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2021 10.35 Mn
Mar 31, 2021 11.77 Mn
Dec 31, 2020 7.35 Mn
Sep 30, 2020 5.56 Mn
Jun 30, 2020 1.39 Mn
API Access

Phathom Pharmaceuticals, Inc. Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=PHAT&period=max&api_key=YOUR_API_KEY